文献速递脑血管病神经重症与神经感染

动脉瘤性蛛网膜下腔出血后1144例患者的抗精神病药使用情况

Antipsychotic Use Among 1144 Patients After Aneurysmal Subarachnoid Hemorrhage.
PubMed 文献 · Stroke · 2019-06-06

该研究基于芬兰东部人群队列,分析1144例动脉瘤性蛛网膜下腔出血(aSAH)后12个月存活者的抗精神病药(APD)使用及其危险因素,并与3432名匹配对照比较。结果显示,aSAH存活者首次启用APD的比例显著高于对照(12% vs 4%),且APD使用与脑损伤迹象(如分流依赖性脑积水)强相关。

要点

  • aSAH后12个月存活者启用APD的比例为12%,显著高于匹配对照的4%。
  • 无显著脑损伤迹象的患者APD启用率低(1年1%,5年2%)。
  • 因脑积水行分流术的患者5年APD启用率最高,达23%。

核心结论

  • aSAH后12个月存活者启用APD的可能性显著高于匹配的普通人群对照。
  • APD使用与aSAH后脑损伤迹象强烈相关,无显著脑损伤者使用率低。

研究设计与样本

  • 基于芬兰东部人群的队列研究,纳入1995至2013年间1144例aSAH后12个月存活者及按年龄、性别、出生市镇匹配的对照3432例(3:1)。
  • 中位随访9年,通过芬兰全国健康登记系统获取药物购买和出院数据。

主要发现

  • 1144例患者中140例(12%)在aSAH后首次启用APD,而3432名对照中仅145例(4%)。
  • APD启用累积率在1年时为6%、5年时为9%,对照组分别为1%和2%。
  • 在489例状态良好(12个月时改良Rankin量表评分0或1,无分流、无脑内出血或脑室内出血)的患者中,1年和5年APD启用率仅为1%和2%。
  • 192例因脑积水行分流术的患者中,5年APD启用率最高,达23%。

临床怎么用

  • aSAH存活者长期随访中应关注精神症状及APD启用情况,尤其对于有脑积水分流等脑损伤迹象的患者。
  • 启用APD时需注意患者常合并使用抗抑郁药或抗癫痫药,应评估药物相互作用及不良反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- At acute phase and neurointensive care, patients with aneurysmal subarachnoid hemorrhage (aSAH) may become agitated or delirious. We found no previous studies on psychotic disorders or antipsychotic drug (APD) use by long-term aSAH survivors. We defined the APD use and its risk factors among 12-month survivors of aSAH in an Eastern Finnish population-based cohort with long-term follow-up. Methods- We analyzed APD use in 1144 consecutive patients with aSAH alive at 12 months of the Kuopio intracranial aneurysm patient and family database and their age, sex, and birth municipality matched controls (3:1; n=3432) from 1995 to 2013 and median follow-up of 9 years. Using the Finish nationwide health registries, we obtained drug purchase and hospital discharge data. Results- In total, 140 (12%) of the 1144 patients started APD use first time after aSAH (index date), in contrast to 145 (4%) of the 3432 matched population controls. The cumulative rate of starting APD was 6% at 1 year and 9% at 5 years, in contrast to 1% and 2% in the controls, respectively. The rates at 1 and 5 years were only 1% and 2% in the 489 patients with a good condition (modified Rankin Scale score, 0 or 1 at 12 months; no shunt, intracerebral hemorrhage, or intraventricular hemorrhage). Instead, the highest rate of APD use, 23% at 5 years was among the 192 patients shunted for hydrocephalus after aSAH. Eighty-eight (63%) of the 140 aSAH patients with APD use had also concomitant antidepressant or antiepileptic drug use. Conclusions- The 12-month survivors of aSAH were significantly more likely to be started on APD after aSAH than their matched population controls. These patients often used antidepressant and antiepileptic drugs concomitantly. The use of APDs strongly correlated with signs of brain injury after aSAH, with low use if no signs of significant brain injury were present.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Paavola JT, Väntti N, Junkkari A, et al. Antipsychotic Use Among 1144 Patients After Aneurysmal Subarachnoid Hemorrhage. Stroke. 2019. PMID: 31167617. doi:10.1161/STROKEAHA.119.024914

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。